FX1

Item no.	HY-102027-10mg
Manufacturer	MedChem Express
CASRN	1426138-42-2
Amount	10 mg
Quantity options	100 mg 10mM/1mL 10 mg 200 mg 25 mg 50 mg 5 mg
Category	Oncology Food Safety Allergenes Neuroscience Neural Lineage Markers Neuroinflammation Inhibitors & Compound Libraries Small Molecules By Organ Lung Cancer Heart & Blood Cancer Bone Cancer
Type	Inhibitors
Specific against	other
Purity	98.0
Formula	C14H9ClN2O4S2
Citations	[1]Mariano G et al. Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma. J Clin Invest. 2016 Sep 1; 126(9): 3351–3362.
Smiles	O=C(O)CCN(C/1=O)C(SC1=C2C(NC3=C/2C=C(Cl)C=C3)=O)=S
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	1426138-42-2
Available
Product Description	FX1 is a potent and specific BCL6 inhibitor, with an IC50 of around 35 μM.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-programmed cell death
MolecularWeight	368.82
Clinical Information	No Development Reported
Manufacturers Research Area	Cancer
Solubility	DMSO : 10 mg/mL (ultrasonic)
Target	Apoptosis; Bcl-2 Family
Manufacturers Target	Apoptosis; Bcl-2 Family
Manufacturers Pathway	Apoptosis
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-102027-10mg-safety-datasheet.pdf